Unknown NA INTERVENTIONAL 2-arm NCT01312688

Early Goal-directed Therapy and Myocardial Dysfunction (SEPT-MD)

The Effect Early Goal-directed Therapy on Myocardial Dysfunction and Survival in ICU Patients With Severe Sepsis and Septic Shock: A Prospective Randomized Controlled Trial

Sponsor: Hadassah Medical Organization

Conditions Myocardial Dysfunction Sepsis Septic Shock

Interventions Early Goal Directed Hemodynamic Therapy in Sepsis

Updated 5 times since 2017 Last updated: Mar 9, 2011 Started: Jul 31, 2011 Primary completion: Jun 30, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01312688, this NA trial focuses on Myocardial Dysfunction and Sepsis and remains ongoing. Sponsored by Hadassah Medical Organization, it has been updated 5 times since 2011, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Jul 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hadassah Medical Organization

Data source: Hadassah Medical Organization

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jerusalem, Israel